Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhongzhi Pharmaceutical Holdings Days Inventory?
Zhongzhi Pharmaceutical HoldingsHKSE:03737 47 Days Inventory is 134.34 as of Dec. 2025, which is 1% below its 10-year median of 135.48. GuruFocus rates HKSE:03737 with a GF Score™ of 47/100 and a GF Value™ of HK$0.89 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 918 Drug Manufacturers companies, Zhongzhi Pharmaceutical Holdings ranks better than 59.8% on this metric.
The historical rank and industry rank for Zhongzhi Pharmaceutical Holdings's Days Inventory or its related term are showing as below:
HKSE:03737'
s Days Inventory Range Over the Past 10 Years
Min: 121.14 Med: 135.48 Max: 149.37
Current: 141.12
During the past 12 years, Zhongzhi Pharmaceutical Holdings's highest Days Inventory was 149.37. The lowest was 121.14. And the median was 135.48.
HKSE:03737's Days Inventory is ranked better than 59.8% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.655
vs HKSE:03737: 141.12
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhongzhi Pharmaceutical Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhongzhi Pharmaceutical Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.34.
Zhongzhi Pharmaceutical Holdings (HKSE:03737) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhongzhi Pharmaceutical Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhongzhi Pharmaceutical Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhongzhi Pharmaceutical Holdings Days Inventory Related Terms
Zhongzhi Pharmaceutical Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongzhi Pharmaceutical Holdings Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongzhi Pharmaceutical Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongzhi Pharmaceutical Holdings (HKSE:03737) has a Days Inventory of 134.34 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhongzhi Pharmaceutical Holdings and its competitors. This is near median its historical median of 135.48. Over the past decade, Zhongzhi Pharmaceutical Holdings' Days Inventory has ranged from 121.14 to 149.37. According to the industry distribution chart, Zhongzhi Pharmaceutical Holdings ranks #369 out of 918 companies in the Drug Manufacturers industry, placing it in the top 40.2%.
Is Zhongzhi Pharmaceutical Holdings' Days Inventory too high?
Zhongzhi Pharmaceutical Holdings' current Days Inventory of 134.34 is near median its 10-year median of 135.48. Over the past 10 years, this metric has ranged from a low of 121.14 to a high of 149.37. The Drug Manufacturers industry median Days Inventory is 164.66. Zhongzhi Pharmaceutical Holdings' value of 134.34 is 18.4% below this industry median. Based on the distribution chart, Zhongzhi Pharmaceutical Holdings ranks #369 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhongzhi Pharmaceutical Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhi Pharmaceutical Holdings' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhongzhi Pharmaceutical Holdings ranks #369 out of 918 companies for Days Inventory. This puts Zhongzhi Pharmaceutical Holdings in the upper half of its industry. The industry median Days Inventory is 164.66. Zhongzhi Pharmaceutical Holdings' value of 134.34 is 18.4% below this benchmark. Historically, Zhongzhi Pharmaceutical Holdings' own Days Inventory has ranged from 121.14 to 149.37 over the past decade. While the company's 10-year median is 135.48 vs. the industry median of 164.66, Zhongzhi Pharmaceutical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.66, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhongzhi Pharmaceutical Holdings's current Days Inventory of 134.34 is 18.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhongzhi Pharmaceutical Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongzhi Pharmaceutical Holdings's current Days Inventory is 134.34, which is near median its own 10-year median of 135.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhi Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhi Pharmaceutical Holdings (HKSE:03737) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.89, compared to a current price of HK$0.71 — trading 20.2% below its estimated fair value. The current Days Inventory is 134.34, which is near median its 10-year median of 135.48 and 18.4% below the Drug Manufacturers industry median of 164.66. Zhongzhi Pharmaceutical Holdings' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhongzhi Pharmaceutical Holdings (HKSE:03737), the current Days Inventory is 134.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongzhi Pharmaceutical Holdings (HKSE:03737) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongzhi Pharmaceutical Holdings stock appears to be undervalued.
The current stock price of HK$0.71 is trading 20.2% below its estimated GF Value™ of HK$0.89.
GuruFocus considers Zhongzhi Pharmaceutical Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:03737:
Days Inventory: 134.34 (near median its 10-year median of 135.48)
GF Value™: HK$0.89 vs. price of HK$0.71 (20.2% below fair value)
Industry Position: 18.4% below the Drug Manufacturers median (#369 of 918)
No single metric tells the full story. See the HKSE:03737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products in the PRC. The Group is a large industrial and trading enterprise group featuring researching, producing, and selling traditional Chinese medicine preparations, prepared slices of Chinese crude drugs, and foods. Its products include Shenqi Koufuye, Yinhuang Jiaonang, Yinhuang Keli, and others. Its segments are the pharmaceutical manufacturing segment, which generates maximum revenue, is engaged in the research and development, manufacturing, and sale of Chinese patent medicines and decoction pieces consisting of traditional decoction pieces and modern decoction pieces, and the operation of the chain pharmacies segment.
47GF Score
Get the complete analysis for HKSE:03737
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03737 has been successfully added to your 
